SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending due to initial alarm from a Stocktwits pricing glitch and concerns over geopolitical events impacting South Korean memory chip rivals, though many in the community argue these events could actually benefit $MU given its limited exposure and strong demand for its AI-driven HBM products ahead of strong earnings expectations.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amidst significant market volatility fueled by escalating geopolitical tensions in the Middle East, which are driving up oil prices and triggering circuit breakers in global markets. The community is sharply divided between those advocating to "buy the dip" and others expressing frustration over perceived market manipulation and the sustainability of current price action, even as government intervention aims to secure energy flows.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF is trending as breaking reports of Iran's Supreme Leader being killed and subsequent negotiation offers ignite intense market volatility. The community is sharply divided between anticipating a short squeeze or a broader downturn, with ongoing concerns about oil prices and geopolitical instability driving widespread debate.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is highly volatile amid escalating Middle East tensions, fueling fears of rising oil prices and inflation, alongside market uncertainty over new tariffs and AI's impact on tech. The community is sharply divided between those bracing for further declines and aggressive dip-buyers anticipating a significant rally or short squeeze in the leveraged tech ETF.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is generating significant debate ahead of its imminent earnings report, as frustrated investors grapple with its continued decline to new 52-week lows, while others point to deep undervaluation and strong fundamentals amidst intense sector competition and geopolitical concerns.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing a surge in attention due to escalating geopolitical tensions highlighting the critical role of drone technology in modern warfare. Community discussion is buzzing with expectations of a short squeeze and imminent results from the Drone Dominance Gauntlet program, which could further solidify the company's position in defense solutions.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

DJIA is trending amidst heightened geopolitical tensions, including ongoing developments in the Middle East and tariff discussions, which are driving broad market volatility. Community sentiment is sharply divided, with some expressing optimism for market resilience and potential gains, while others voice concerns about a broader economic downturn and market vulnerability.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is seeing a tug-of-war in sentiment as traders weigh geopolitical tensions in the Middle East and upcoming Nvidia earnings against ongoing strong AI demand for semiconductors. The community is sharply divided, with some actively "buying the dip" and others warning of a significant pullback due to leveraged ETF decay and broader market uncertainty.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is a hot topic following an earnings call that showcased robust ANKTIVA revenue growth and plans for immediate global product shipments, sparking community debate between long-term optimism for a cancer cure and short-term investor disappointment over financial guidance amidst active short-seller sentiment.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

EWY is trending as South Korea's market experienced a significant decline, triggering circuit breakers amid surging oil and LNG prices fueled by geopolitical tensions, which led to a massive sell-off in key semiconductor holdings like Samsung and SK Hynix; the community is actively debating whether this represents an excessive correction and a prime buying opportunity or a sign of an over-extended market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rigel Pharmaceuticals Q4 Earnings Call Highlights

Rigel Pharmaceuticals (NASDAQ:RIGL) detailed record commercial performance for the fourth quarter and full year 2025, while outlining plans to pursue additional in-licensing opportunities and advance...

Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates

Rigel (RIGL) delivered earnings and revenue surprises of -14.29% and 0.00%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Summary: Rigel Pharmaceuticals Q4

Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings Results

Rigel Pharmaceuticals (NASDAQ:RIGL - Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported $13.54 earnings per share (EPS) for the quarter, beating...

Sanofi's Wayrilz Gets Orphan Drug Tag for IgG4-Related Disease in Japan

SNY wins Japan orphan drug tag for Waylirz in IgG4-RD and adds regulatory perks as the BTK inhibitor advances in late-stage studies.

A Preview Of Rigel Pharmaceuticals's Earnings

Implied Volatility Surging for Rigel Pharmaceuticals Stock Options

Investors need to pay close attention to RIGL stock based on the movements in the options market lately.

Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline

Profound Medical (PROF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of +86.00% and +30.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Rigel Pharmaceuticals (NASDAQ:RIGL) Director Walter Moos Sells 4,000 Shares

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) Director Walter Moos sold 4,000 shares of Rigel Pharmaceuticals stock in a transaction on Friday, February 20th. The stock was sold at an...

$RIGL Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY
• Rigel Pharmaceuticals expects existing capital resources to fund its expenses and capital expenditure requirements through at least the next 12 months from the 10-K filing date.

Stocktwits

Rigel Pharmaceuticals

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY
• Rigel Pharmaceuticals expects existing capital resources to fund its expenses and capital expenditure requirements through at least the next 12 months from the 10-K filing date.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

$RIGL Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $14.72 up 1717.28% YoY
• Reported revenue of $69.8M up 21.19% YoY

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Current Price	$33.02
Prev Close	$34.62
Open	$34.12
Dividend Yield	0.00%
50-Day Moving Average	$38.18
Beta	1.35
Avg. Volume	290,779.77
PE Ratio	5.61

52-Week High	$52.24
52-Week Low	$15.50
Market Capitalization	$628.4M
EPS (Annual)	$0.9886
Price to Book	5.34
Revenue Per Employee	$1.09M

RIGL
Rigel Pharmaceuticals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RIGL News

RIGLRigel Pharmaceuticals